Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Baer

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Leukemia|December 15, 2010
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaL Yu, J C Reader, C Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia|April 12, 2003
HLA-DR antigen-negative acute myeloid leukemiaM Wetzler, B K McElwain, C C Stewart, et al.
Leukemia|April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometryM R Baer, C C Stewart, D Lawrence, et al.
Leukemia Research|May 5, 2001
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemiaZ Xia, S N Sait, M R Baer, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Leukemia Research|July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasmsJ Berdeja, F Palandri, M R Baer, et al.
American Journal of Hematology|May 1, 1995
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB studyF R Davey, N Abraham, V L Brunetto, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Leukemia|December 15, 2010
Activation of a novel palmitoyltransferase ZDHHC14 in acute biphenotypic leukemia and subsets of acute myeloid leukemiaL Yu, J C Reader, C Chen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1997
Expression of c-mpl mRNA, the receptor for thrombopoietin, in acute myeloid leukemia blasts identifies a group of patients with poor response to intensive chemotherapyM Wetzler, M R Baer, S H Bernstein, et al.
Leukemia|April 12, 2003
HLA-DR antigen-negative acute myeloid leukemiaM Wetzler, B K McElwain, C C Stewart, et al.
Leukemia|April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometryM R Baer, C C Stewart, D Lawrence, et al.
Leukemia Research|May 5, 2001
Truncated STAT proteins are prevalent at relapse of acute myeloid leukemiaZ Xia, S N Sait, M R Baer, et al.
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
Leukemia|January 30, 2010
Phase I study of the heat shock protein 90 inhibitor alvespimycin (KOS-1022, 17-DMAG) administered intravenously twice weekly to patients with acute myeloid leukemiaJ E Lancet, I Gojo, M Burton, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Leukemia Research|July 20, 2018
Phase 2 study of gandotinib (LY2784544) in patients with myeloproliferative neoplasmsJ Berdeja, F Palandri, M R Baer, et al.
American Journal of Hematology|May 1, 1995
Morphologic characteristics of erythroleukemia (acute myeloid leukemia; FAB-M6): a CALGB studyF R Davey, N Abraham, V L Brunetto, et al.
Pageof 10